A clinician reminds patients on GLP-1 medications that their bodies are not flawed or broken. A short brand post with a body-positive message.
Recap by typeshit. Post by @standardprocess on Instagram.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Sara Ashley O'Brien reports on a growing number of teen boys using peptides, supplements and online advice to change how they look and feel.
Lilly reports all three doses met their goals at 80 weeks, with about 11% quitting on 12 mg and 13% reporting dysesthesia. Shares rose about 1% premarket.
Loading…